Pages

Saturday, July 14, 2018

Soligenix receives European, Canadian patents for its ricin toxin vaccine (RiVax) formulation

Soligenix receives European, Canadian patents for its ricin toxin vaccine (RiVax) formulation: The Best in uncensored news, information, and analysis

No comments: